270
Participants
Start Date
April 11, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
December 31, 2026
Relacorilant 150 mg once daily (QD)
Relacorilant is administered under fed conditions as capsules for oral dosing on the day before, the day of, and the day after nab-paclitaxel infusion.
Nab-paclitaxel 80 mg/m^2
Nab-paclitaxel is administered as IV infusion on Days 1, 8, and 15 of each 28-day cycle.
Bevacizumab 10 mg/kg
Bevacizumab is administered as IV infusion on Days 1 and 15.
RECRUITING
108, Leuven
RECRUITING
325, Hasselt
RECRUITING
326, Charleroi
RECRUITING
328, Aalst
RECRUITING
255, Berlin
RECRUITING
293, Torino
RECRUITING
397, Gyeonggi-do
RECRUITING
127, Pittsburgh
RECRUITING
122, Milan
RECRUITING
516, Milan
RECRUITING
522, Fairfax
RECRUITING
323, Plérin
RECRUITING
300, Norfolk
RECRUITING
295, Pavia
RECRUITING
308, Toulouse
RECRUITING
319, Treviso
RECRUITING
543, West Palm Beach
RECRUITING
544, Fort Myers
RECRUITING
304, Centerville
RECRUITING
330, Valencia
RECRUITING
519, Aachen
RECRUITING
121, Milwaukee
RECRUITING
307, Nancy
RECRUITING
518, Minneapolis
RECRUITING
306, Lille
RECRUITING
521, St Louis
RECRUITING
334, Kansas City
RECRUITING
324, Pierre-Bénite
RECRUITING
520, Kempten
RECRUITING
014, San Francisco
RECRUITING
150, Palo Alto
RECRUITING
321, Catania
RECRUITING
292, Albuquerque
RECRUITING
517, Eugene
RECRUITING
310, Nice
RECRUITING
124, Rome
RECRUITING
341, Gdynia
RECRUITING
329, Siedlce
RECRUITING
396, Seoul
RECRUITING
399, Seoul
RECRUITING
523, Seoul
RECRUITING
398, Seoul
RECRUITING
403, Seoul
RECRUITING
349, Badalona
RECRUITING
115, Barcelona
Lead Sponsor
Corcept Therapeutics
INDUSTRY